Sotera Health Confirms Preliminary 2022 Full-Year Guidance in Conjunction with Incremental Debt Financing
CLEVELAND, Feb. 13, 2023 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its intention to enter into a new senior secured Term Loan B facility in an aggregate principal amount of $425 million, which is expected to fund and close during the first quarter. The Company plans to use proceeds of this debt financing, along with cash on hand, to: a) fund a previously announced planned $408 million ethylene oxide litigation settlement in Cook County, IL, b) pay down existing borrowings under the Company’s revolving credit facility, and c) further enhance liquidity.
Related news for (SHC)
- Today’s Top Performers: MoBot’s Market Review 08/08/25 05:00 PM
- MoBot alert highlights: NASDAQ: AUUD, NASDAQ: WLGS, NASDAQ: GMHS, NASDAQ: SHC, NASDAQ: RAYA (08/08/25 04:00 PM)
- MoBot alert highlights: NASDAQ: SMX, NASDAQ: SHC, NASDAQ: BTAI, NASDAQ: VVPR, NYSE: EB (08/08/25 11:00 AM)
- Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference
- Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference